An experimental medication developed by Eli Lilly to slow the progress of dementia failed to show any benefit during a large-scale trial. (Photo: iStock)

As life expectancies increase and a greater portion of our society lives in old age, the search for solutions to dementia are taking on a new urgency as families and the health care system cope with the emotional and financial toll of millions of cognitively-impaired Americans. 

On Sunday, the CBS new program “60 Minutes” put a spotlight on the researchers who are seeking ways to prevent the onset of the Alzheimer’s, which afflicts roughly 1 percent of people by age 60 and nearly 40 percent of those who reach 85, according to one expert interviewed for the segment. 

Complete your profile to continue reading and get FREE access to, part of your ALM digital membership.

Your access to unlimited content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Critical information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
  • Exclusive discounts on ALM, BenefitsPRO magazine and events.
  • Access to other award-winning ALM websites including and

Already have an account?


© 2023 ALM Global, LLC, All Rights Reserved. Request academic re-use from All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.

Jack Craver


Join BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join now!

  • Unlimited access to - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including and
  • Exclusive discounts on and ALM events.

Already have an account? Sign In Now
Join BenefitsPRO

Copyright © 2023 ALM Global, LLC. All Rights Reserved.